Dipna Pharmachem Ltd

Wed 18/11/2026,16:1:0 | BSE : DPL

₹4.01-0.03 (-0.74%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 4.01

Previous Close

₹ 4.04

Volume

12000

Mkt Cap ( ₹ Cr)

₹ 10.54

High

₹ 4.02

Low

₹ 4.01

52 Week High

₹ 18.90

52 Week Low

₹ 3.62

Book Value Per Share

₹ 16.03

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Dipna Pharmachem Ltd

Your Vote -

Buy

50.00%

Hold

25.00%

Sell

25.00%

50.00%

4 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Dipna Pharmachem Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Dipna Pharmachem Q1 net profit down 31.58% at Rs 0.39 cr

    5 Nov 2026, 11:20AM The company reported standalone net profit of Rs 0.39 crore for the quarter ended June 30, 2026 as compared to Rs 0.57 crore in the same period last y
  • Dipna Pharmachem - Integrated Filing (Finance) For The Quarter Ended On 30Th June, 2026

    4 Nov 2026, 5:52PM Integrated Filing
  • Dipna Pharmachem - Outcome Of Board Meeting Held Today I.E. 4Th November, 2026

    4 Nov 2026, 5:48PM Outcome of Board Meeting held today i.e. 4th November, 2026
  • Dipna Pharmachem - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 4Th November, 2026

    4 Nov 2026, 5:41PM Outcome of Board Meeting held today i.e. 4th November, 2026
  • Dipna Pharmachem - Reconstitution Of The Committee

    3 Nov 2026, 8:10PM Reconstitution of the Committee
  • Dipna Pharmachem - Announcement under Regulation 30 (LODR)-Change in Directorate

    3 Nov 2026, 8:07PM Outcome and Intimation Under Regulation 30 of SEBI (LODR) Regulations, 2015
  • Dipna Pharmachem - Board Meeting Outcome for Outcome And Intimation Under Regulation 30 Of The SEBI (Listing Obligations And\

    3 Nov 2026, 8:05PM Outcome and Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • Dipna Pharmachem - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday 4Th November, 2026

    31 Oct 2026, 6:50PM Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and
  • Dipna Pharmachem - Outcome And Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) R

    24 Oct 2026, 4:55PM Outcome and Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • Dipna Pharmachem - Announcement under Regulation 30 (LODR)-Resignation of Director

    24 Oct 2026, 4:43PM Announcement under Regulation 30 (LODR) - Resignation of Director
  • Dipna Pharmachem - Announcement under Regulation 30 (LODR)-Change in Directorate

    24 Oct 2026, 4:38PM Announcement under Regulation 30 (LODR) - Change in Directorate
  • Dipna Pharmachem - Board Meeting Outcome for Outcome And Intimation Under Regulation 30 Of The SEBI (Listing Obligations And

    24 Oct 2026, 4:29PM Outcome and Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015\r\n
  • Dipna Pharmachem - Appointment of Company Secretary and Compliance Officer

    23 Oct 2026, 7:15PM Appointment of Company Secretary and Compliance Officer
  • Dipna Pharmachem - Board Meeting Outcome for Outcome And Intimation Under Regulation 30 Of The SEBI (Listing Obligations And

    23 Oct 2026, 7:04PM Outcome and Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015\r\n
  • Dipna Pharmachem has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2026

    21 Oct 2026, 7:50PM As of September 2026, 9.13% is owned by Indian Promoters and 90.87% by Public. <p align=justify> Top two Promoters holding highest number of shares of
  • Dipna Pharmachem - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    19 Oct 2026, 4:50PM Submission of Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on 30th September, 20

Key fundamentals

Evaluate the intrinsic value of Dipna Pharmachem Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 55.7156 56.9637 40.2656 11.9274 12.9981
Liabilities 55.7156 56.9637 40.2656 11.9274 12.9981
Equity 24.0453 24.0453 11.97 0.035 0.035
Gross Profit 3.4343 3.4284 2.343 2.2444 0.3998
Net Profit 0.9741 1.0853 0.9119 1.1669 0.0242
Cash From Operating Activities -9.1946 -5.4165 -20.9762 2.8655 -2.4324
NPM(%) 0.77 0.66 0.91 1.6 0.07
Revenue 124.9171 164.3371 99.9272 72.7554 30.9999
Expenses 121.4828 160.9087 97.5841 70.511 30.6001
ROE(%) 2.31 2.57 2.16 2.76 0.05

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Dipna Pharmachem Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 751.60 -2.39 15.09 2.29 -26.19 0.66
Lotus Eye Hospital and Institute Ltd 102.45 -2.84 460.45 8.34 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 8.88 -1.44 0.00 17.32 -39.50 0.00
Astec Lifesciences Ltd 546.80 -2.05 0.00 8.94 -363.14 0.00

Company Info

The Company was originally incorporated as "Dipan Pharmachem Private Limited` as Private Limited Company under the provisions of Companies Act, 1956 vide Certificate of Incorporation dated July19, 2011 bearing Corporate Identification Number U24100GJ2011PTC066400 issued by the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. The name of the Company was changed to "Dipna Pharmachem Private Limited" and a fresh certificate of Incorporation was issued on March 29, 2012 bearing Corporate Identification Number Co. No. U24100GJ2011PTC066400by the Registrar of Companies, Gujarat, Dadra and Nagar Haveli. Subsequently, the Company was converted in to a public limited Company pursuant to a special resolution passed by the shareholders at the EGM held on May 13, 2022 and consequently the name of the Company was changed to "Dipna Pharmachem Limited" and a fresh certificate of incorporation was issued by the Registrar of Companies, Ahmedabad dated May 25, 2022. The CIN of the Company is U24100GJ2011PLC066400. 2024 -The company issued rights shares of Rs. 10 in the ratio of 13:12 at par.

The Company was originally incorporated as "Dipan Pharmachem Private Limited` as Private Limited Company under the provisions of Companies Act, 1956 vide Certificate of Incorporation dated July19, 2011 bearing Corporate Identification Number U24100GJ2011PTC066400 issued by the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. The name of the Company was changed to "Dipna Pharmachem Private Limited" and a fresh certificate of Incorporation was issued on March 29, 2012 bearing Corporate Identification Number Co. No. U24100GJ2011PTC066400by the Registrar of Companies, Gujarat, Dadra and Nagar Haveli. Subsequently, the Company was converted in to a public limited Company pursuant to a special resolution passed by the shareholders at the EGM held on May 13, 2022 and consequently the name of the Company was changed to "Dipna Pharmachem Limited" and a fresh certificate of incorporation was issued by the Registrar of Companies, Ahmedabad dated May 25, 2022. The CIN of the Company is U24100GJ2011PLC066400. 2024 -The company issued rights shares of Rs. 10 in the ratio of 13:12 at par.

Parent Organisation

Dipna Pharmachem Ltd.

Founded

19/07/2011

Managing Director

Mr.Keyur Dipakkumar Shah

NSE Symbol

FAQ